share_log

中國中藥：高級管理人員辭任及董事調任

TRAD CHI MED: RESIGNATION OF MEMBERS OF SENIOR MANAGEMENT AND RE-DESIGNATION OF DIRECTORS

香港交易所 ·  Mar 21 09:17
Summary by Moomoo AI
中國中藥控股有限公司宣布，因達到法定退休年齡，程學仁先生和楊文明先生已辭去高級管理職務，並自2024年3月21日起調任為非執行董事。同日，執行董事及董事會主席陳映龍先生將代行總裁職務。程先生和楊先生將繼續擔任董事會提名委員會和戰略委員會成員。此外，公司提及先前於2024年2月21日發布的聯合公告，關於國藥集團共裕有限公司提出的私有化建議，並已成立獨立委員會評估該建議。程先生和楊先生因與控股股東有關聯，不會成為該獨立委員會成員。
中國中藥控股有限公司宣布，因達到法定退休年齡，程學仁先生和楊文明先生已辭去高級管理職務，並自2024年3月21日起調任為非執行董事。同日，執行董事及董事會主席陳映龍先生將代行總裁職務。程先生和楊先生將繼續擔任董事會提名委員會和戰略委員會成員。此外，公司提及先前於2024年2月21日發布的聯合公告，關於國藥集團共裕有限公司提出的私有化建議，並已成立獨立委員會評估該建議。程先生和楊先生因與控股股東有關聯，不會成為該獨立委員會成員。
China Pharmaceutical Holdings Limited announced that Mr. Cheng Shu Yan and Mr. Yang Wenming have resigned from their senior management positions and will be appointed as non-executive directors effective March 21, 2024. On the same day, the Executive Director and Chairman of the Board Mr. Chen Yinglong will serve as acting President. Mr. Cheng and Mr. Yang will continue to serve as members of the Nominating Committee and Strategic Committee of the Board. In addition, the Company refers to the Joint Announcement previously issued on 21 February 2024 regarding the privatization proposal made by Kongyue Yue Co., Ltd., and an independent committee has been set up to evaluate the proposal. Mr. Cheng and Mr. Yang will not be members of the Independent Committee due to their affiliation with the controlling shareholders.
China Pharmaceutical Holdings Limited announced that Mr. Cheng Shu Yan and Mr. Yang Wenming have resigned from their senior management positions and will be appointed as non-executive directors effective March 21, 2024. On the same day, the Executive Director and Chairman of the Board Mr. Chen Yinglong will serve as acting President. Mr. Cheng and Mr. Yang will continue to serve as members of the Nominating Committee and Strategic Committee of the Board. In addition, the Company refers to the Joint Announcement previously issued on 21 February 2024 regarding the privatization proposal made by Kongyue Yue Co., Ltd., and an independent committee has been set up to evaluate the proposal. Mr. Cheng and Mr. Yang will not be members of the Independent Committee due to their affiliation with the controlling shareholders.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more